OneOncology will embed OpenEvidence’s AI chatbot and search engine directly into community oncology clinics, aiming to support physician decision-making and literature search at the point of care. The integration is planned alongside expansion toward workflow tools for workups and genomic and clinical trial matching, built partly through prior collaborations. OpenEvidence says the system is HIPAA compliant and that it has partnered with NCCN and major journals for reference material, while OneOncology frames oncology as an information-heavy environment where clinicians need fast access to guidelines-backed biomarkers and newly approved targeted therapies.